BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2022
View Archived Issues
NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC
Read More
Shengke Pharmaceuticals discovers FLT inhibitors
Read More
New lysine-specific demethylase 5B inhibitors identified at FibroGen
Read More
New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics
Read More
Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides
Read More
TIMP-1 and CKM are biomarkers of treatment response in DMD
Read More
New rat model may shed light on mechanisms behind CSVD pathogenesis
Read More
New GSK-3 inhibitors patented by Ramot at Tel Aviv University, Bar-Ilan University
Read More
RGX-202 improves muscle function and dystrophic muscle pathology in mice
Read More
Blood stem cells treat brain disease after transplant
Read More
Discovery of novel S1PR2 ligands as tracers for neuroimaging
Read More
PepGen presents promising preclinical data for PGN-EDO51
Read More
ETC-642 increases plasma HDL and protects mice from sepsis
Read More
Sanofi and Seagen to develop and commercialize antibody-drug conjugates for cancer targets
Read More
Oppilotech partners with Evariste on first-in-class antibacterial program
Read More
Sareum receives final preclinical toxicology report for SDC-1801
Read More
In vivo pharmacokinetic data confirm BETR-001 bioavailability in target brain tissue
Read More
